Russell T. Kronengold
Nessuna posizione attualmente
Storia della carriera di Russell T. Kronengold
Precedenti posizioni note di Russell T. Kronengold
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
DSM Biomedical, Inc.
 DSM Biomedical, Inc. Medical SpecialtiesHealth Technology DSM Biomedical, Inc. manufactures and designs medical device materials. The firm's products include bioceramics, polyurethanes, device development, hydrophilic coating solutions, polyethylenes, collagen, and extracellular matrix and drug delivery materials. The company was founded by Kenneth R. Kensey and John E. Nash in 1984 and is headquartered in Exton, PA. | Corporate Officer/Principal | 01/01/1997 | 15/02/2010 |
| APERION BIOLOGICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/02/2010 | - |
Formazione di Russell T. Kronengold
| University of Medicine & Dentistry of New Jersey | Doctorate Degree |
| Rutgers State University of New Jersey | Graduate Degree |
| Carnegie Mellon University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Francia | 2 |
Posizioni
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 2 |
| Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
DSM Biomedical, Inc.
DSM Biomedical, Inc. Medical SpecialtiesHealth Technology DSM Biomedical, Inc. manufactures and designs medical device materials. The firm's products include bioceramics, polyurethanes, device development, hydrophilic coating solutions, polyethylenes, collagen, and extracellular matrix and drug delivery materials. The company was founded by Kenneth R. Kensey and John E. Nash in 1984 and is headquartered in Exton, PA. | Health Technology |
Aperion Biologics, Inc.
 Aperion Biologics, Inc. Medical DistributorsDistribution Services Aperion Biologics, Inc. engages in the development and implementation of its business plans, performing research on its platform technology, conducting clinical trials on its products in both animals and humans, pursuing regulatory approvals to market its product in U.S. and international markets, and raising capital. The firm's core platform technology is an enzymatic stripping of the key carbohydrate antigens followed by a unique conversion process that both humanizes and sterilizes the tissues without affecting their biomechanical or biological properties. The company was founded by Kevin Robert Stone in October 1996 and is headquartered in San Antonio, TX. | Distribution Services |
